Yungjin Pharm.
영진약품KRX: 003520· Fiscal year 2025· yungjin.co.kr ↗
Average salary
$51.9K
₩69.2M
▲ 6.0% vs 2024
Employees
626
▼ 0.3% vs 2024
Average tenure
Not disclosed
Estimated take-home of this pay:$3.5K / monthCalculate →
Workplace
Women's pay (men = 100)86
Women among staff30.7%
Contract staff6.7%
Recent official filings
- 2026-11-17Investor relations (IR) event
- 2026-11-13Quarterly report (2026.09)
- 2026-11-04Preliminary earnings
- 2026-09-01MajorLawsuit
- 2026-08-14Half-year report (2026.06)
- 2026-07-31Preliminary earnings
Quick read
- Average pay is 13% above the median of the companies we track.
- Average pay rose 6.0% from 2024.
- Headcount shrank by 2 (0.3%) from 2024.
- Ranks #50 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 0.9% year over year.
- Revenue has grown two years in a row.
- Operating margin was 1.3% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $304.1K
- Net profit per employee
- -$272
- Operating margin
- 1.3%
- Net margin
- -0.1%
- ROE
- -0.2%
- Debt-to-equity
- 186.9%
- Equity ratio
- 34.9%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.